Document:

Document

Exhibit 10.11

AMENDMENT NO. 3
TO THE
CHANGE OF CONTROL SEVERANCE AGREEMENT

This Amendment No. 3 (“Amendment”) is entered into as of June 10, 2022 (“Amendment Effective Date”) by and between Quotient Technology, Inc. (“Company”) and Connie Chen (“Executive”), to amend the Change of Control Severance Agreement by and between Company and Executive effective July 26, 2016, as amended effective as of May 1, 2019 and May 1, 2022 (“Agreement”).  All capitalized terms not defined herein shall have the meanings assigned to them in the Agreement.
WHEREAS, the Compensation Committee of the Board of Directors of the Company has determined that it is in the best interests of the Company to provide enhanced severance benefits to the Executive for three (3) years for retention purposes.
NOW THEREFORE, in consideration of the foregoing and the mutual promises and covenants herein contained, the receipt and sufficiency of which is hereby acknowledged, Company and Executive hereby agree to amend the Agreement as follows: 
1.Section 3(a)(ii) is hereby amended to add the following as a last sentence: “In lieu of the foregoing benefits, if Executive’s termination date under this section occurs between June 10, 2022 through and including June 10, 2025 (the “Retention Period”), Executive will receive a lump-sum payment (less applicable withholding taxes) equal to one hundred fifty percent (150%) of Executive’s annual base salary as in effect immediately prior to Executive’s termination date.”

2.Section 3(a)(iii) is hereby amended to add the following as a last sentence: “In the event that Executive’s termination date occurs during the Retention Period, the number nine (9) shall be replaced with the number eighteen (18).”

3.Section 3(a) is hereby amended to add a new Section 3(a)(iv) which reads as follows:

(iv)   Accelerated Vesting of Equity Awards.  If Executive’s termination date under this section occurs during the Retention Period, fifty percent (50%) of the total number of shares subject to Executive’s then outstanding and unvested Equity Awards subject solely to time-based vesting conditions will vest and become exercisable, as applicable.

4.Section 3(a) is hereby amended to add a new Section 3(a)(v) which reads as follows:

(v)   Bonus Payment.  If Executive’s termination date under this section occurs during the Retention Period, Executive will receive a lump-sum payment (less applicable withholding taxes) equal to one hundred fifty percent (150%) of Executive’s annual bonus for the year of termination at target level as in effect immediately prior to Executive’s termination date.

5.Section 3(b)(ii) is hereby amended to add the following as a last sentence: “In lieu of the foregoing, if Executive’s termination date under this section occurs during the Retention Period, Executive will receive a lump-sum payment (less applicable withholding taxes) equal to one 
    1

hundred fifty percent (150%) of Executive’s annual base salary as in effect immediately prior to Executive’s termination date (or if the termination is due to a resignation for Good Reason based on a material reduction in base salary, then Executive’s annual base salary in effect immediately prior to such reduction) or, if greater, at the level in effect immediately prior to the Change of Control.”

6.Section 3(b)(iii) is hereby amended to add the following as a last sentence: “In lieu of the foregoing, if Executive’s termination date under this section occurs during the Retention Period, Executive will receive a lump-sum payment (less applicable withholding taxes) equal to one hundred fifty percent (150%) of Executive’s annual bonus for the year of termination at target level as in effect immediately prior to Executive’s termination date (and for purposes of clarification, if Executive’s annual bonus target is expressed as a percentage of Executive’s annual base salary and Executive’s termination is due to a resignation for Good Reason based on a material reduction in base salary, then the payment to be made pursuant to this section will be calculated based on Executive’s annual base salary in effect immediately prior to such reduction), or, if greater, at the level in effect immediately prior to the Change of Control.”

7.Section 3(b)(iv) is hereby amended to add the following as a last sentence: “In the event that Executive’s termination date occurs during the Retention Period, the number twelve (12) shall be replaced with the number eighteen (18).”
Except as specifically provided in this Amendment, the terms and conditions of the Agreement remain in full force and effect. This Amendment may be executed in counterparts, which together will constitute one document and be binding on all of the parties herein.
    2

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their duly authorized representatives as of the Amendment Effective Date.
						
	EXECUTIVE	QUOTIENT TECHNOLOGY INC. 
	By: /s/ Connie Chen            
	By: /s/ Matt Krepsik            

	Name: Connie Chen            
	Name: Matt Krepsik            

	Title: General Counsel            
	Title: Chief Executive Officer        

	Date: June 10, 2022            
	Date: June 13, 2022            

[Signature page of Amendment No. 3 to the Change of Control Severance Agreement]

    3Exhibit 4.2

 

Option Number XX-XXXX-X

 

180 LIFE SCIENCES CORP.

 

2022 OMNIBUS INCENTIVE PLAN

 

STOCK OPTION AGREEMENT

 

Unless otherwise defined herein,
the terms in the Stock Option Agreement (the “Option Agreement”) have the same meanings as defined in the 180
Life Sciences Corp. 2022 Omnibus Incentive Plan (as amended from time to time)(the “Plan”).

 

		I.	NOTICE OF STOCK OPTION GRANT

 

Optionee: <<Optionee>>

 

Address: ___________________________________

 

You have been granted an Option
to purchase Company Common Stock of the Company (the “Option”), subject to the terms and conditions of the Plan
and this Option Agreement, as follows:

 

Grant Date: <<Grant
Date>>

 

Vesting Commencement Date: <<Grant
Date>>

 

Exercise Price per Share:
$<<Exercise Price>>

 

Total Number of Shares
Granted: <<Total Shares>>

 

Total Exercise Price: $<<Total
Exercise Price>>

 

Type of Option: ________________________

 

Expiration Date: ________________________

 

Vesting Schedule: The
Options vest at the rate of ________________________, subject to the Optionee’s continued service to the Company.
Notwithstanding the above, all of the unvested Options shall vest immediately upon Optionee’s death or Disability, termination of
employment without cause or a termination of Optionee for good reason (each as defined and described in Optionee’s employment agreement),
a Change in Control of the Company.

 

     

     

    

 

To the extent vested, this
Option will be exercisable for three (3) months following the termination of service of Optionee, unless termination is due to Optionee’s
death or Disability, in which case this Option will be exercisable for twelve (12) months following the termination of service
of Optionee. In the event of termination due to Optionee’s death, the Company shall use commercially reasonable efforts to notify
Optionee’s estate of the exercisability of the Option following Optionee’s death. Notwithstanding the foregoing sentence,
in no event may this Option be exercised following the termination of service of Optionee as determined by the Company’s Board to
be for Cause or after the Expiration Date as provided above and this Option may be subject to earlier termination as provided in the Plan.

 

“Cause”
has the meaning ascribed to such term or words of similar import in Optionee’s written employment or service contract with the Company
or its parent or any subsidiary and, in the absence of such agreement or definition, means Optionee’s (i) conviction of, or
plea of nolo contendere to, a felony or any other crime involving moral turpitude; (ii) fraud on or misappropriation of any funds
or property of the Company or its subsidiaries, or any affiliate, customer or vendor; (iii) personal dishonesty, incompetence, willful
misconduct, willful violation of any law, rule or regulation (other than minor traffic violations or similar offenses), or breach of fiduciary
duty which involves personal profit; (iv) willful misconduct in connection with Optionee’s duties or willful failure to perform
Optionee’s responsibilities in the best interests of the Company or its subsidiaries; (v) illegal use or distribution of drugs;
(vi) violation of any material rule, regulation, procedure or policy of the Company or its subsidiaries, the violation of which could
have a material detriment to the Company; or (vii) material breach of any provision of any employment, non-disclosure, non-competition,
non-solicitation or other similar agreement executed by Optionee for the benefit of the Company or its subsidiaries, all as reasonably
determined by the Company’s Board of Directors, which determination will be conclusive.

 

Legends.

 

(a)
All certificates representing the Shares issued upon exercise of this Option shall, prior to such date as the Plan and Company
Common Stock hereunder are covered by a valid Form S-8 or similar U.S. federal registration statement, where applicable, have endorsed
thereon the following legend:

 

THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES
LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS
OF U.S. FEDERAL, STATE AND FOREIGN SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT
REGISTRATION AND QUALIFICATION UNDER U.S. FEDERAL, STATE AND FOREIGN SECURITIES LAWS IS NOT REQUIRED.

 

(b)
If the Option is an incentive stock option (ISO), then the following legend will be included:

 

THE SHARES
REPRESENTED BY THIS CERTIFICATE WERE ISSUED UPON EXERCISE OF AN INCENTIVE STOCK OPTION, AND THE COMPANY MUST BE NOTIFIED IF THE SHARES
SHALL BE TRANSFERRED BEFORE THE LATER OF THE TWO (2) YEAR ANNIVERSARY OF THE DATE OF GRANT OF THE OPTION OR THE ONE (1) YEAR ANNIVERSARY
OF THE DATE ON WHICH THE OPTION WAS EXERCISED. THE REGISTERED HOLDER MAY RECOGNIZE ORDINARY INCOME IF THE SHARES ARE TRANSFERRED BEFORE
SUCH DATE.

 

    2022 Stock Option Agreement
Option Number XX-XXXX-X
Page 2 of 9

     

    

 

II. AGREEMENT

 

1. Grant of Option.
The Administrator grants to the Optionee named in the Notice of Stock Option Grant in Part I of this Option Agreement,
an Option to purchase the number of Shares set forth in the Notice of Stock Option Grant, at the exercise price per Share set forth in
the Notice of Stock Option Grant (the “Exercise Price”), and subject to the terms and conditions of the Plan,
which is incorporated herein by reference. In the event of a conflict between the terms and conditions of the Plan and this Option Agreement,
the terms and conditions of the Plan prevail.

 

If designated in the Notice
of Stock Option Grant as an Incentive Stock Option, this Option is intended to qualify as an Incentive Stock Option as defined in Code
section 422. Nevertheless, to the extent that it exceeds the $100,000 rule of Code section 422(d), this Option will be treated
as a Nonstatutory/Non-Qualified Stock Option.

 

2. Exercise of Option.

 

(a) Right to Exercise.
This Option is exercisable during its term in accordance with the Vesting Schedule set out in the Notice of Stock Option Grant and with
the applicable provisions of the Plan and this Option Agreement.

 

(b) Method of Exercise.
This Option is exercisable by (i) delivery of an exercise notice in the form attached as Exhibit A (the “Exercise
Notice”) or in a manner and pursuant to procedures as the Administrator may determine, which will state the election to
exercise the Option, the number of Shares with respect to which the Option is being exercised, and other representations and agreements
as may be required by the Company and (ii) paying the Company in full the aggregate Exercise Price as to all Shares being acquired, together
with any applicable tax withholding.

 

This Option will be deemed to
be exercised upon receipt by the Company of a fully executed Exercise Notice accompanied by the aggregate Exercise Price, together with
any applicable tax withholding.

 

No Shares will be issued pursuant
to the exercise of an Option unless the issuance and exercise of Shares complies with applicable state and federal laws (“Applicable
Laws”). Assuming compliance, for income tax purposes the Shares will be considered transferred to the Optionee on the date
on which the Option is exercised with respect to the Shares.

 

3. Method of Payment.
The aggregate Exercise Price may be paid by any of the following, or a combination thereof, at the election of the Optionee:

 

(a) cash;

 

(b) check;

 

(c) to the extent not prohibited
by Section 402 of the Sarbanes-Oxley Act of 2002, a promissory note;

 

(d) other shares of Company
Common Stock, provided Shares have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as
to which said Option will be exercised;

 

(e) by asking the Company to
withhold Shares from the total Shares to be delivered upon exercise equal to the number of Shares having a value equal to the aggregate
Exercise Price of the Shares being acquired;

 

(f) any combination of the foregoing
methods of payment; or

 

(g) such other consideration
and method of payment for the issuance of Shares to the extent permitted by Applicable Laws.

 

    2022 Stock Option Agreement
Option Number XX-XXXX-X
Page 3 of 9

     

    

 

4. Restrictions on
Exercise. This Option may not be exercised if the issuance of such Shares upon such exercise or the method of payment of consideration
for such shares would constitute a violation of any Applicable Laws. The Company will be relieved of any liability with respect to any
delayed issuance of shares or its failure to issue shares if such delay or failure is necessary to comply with Applicable Laws.

 

5. Non-Transferability
of Option. This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may
be exercised during the lifetime of Optionee only by Optionee. The terms of the Plan and this Option Agreement are binding upon the executors,
administrators, heirs, successors and assigns of the Optionee.

 

6. Term of Option.
This Option may be exercised only within the term set out in the Notice of Stock Option Grant, and may be exercised during the term only
in accordance with the Plan and the terms of this Option.

 

7. Tax Obligations.

 

(a) Withholding Taxes.
Optionee agrees to arrange for the satisfaction of all Federal, state, local and foreign income and employment tax withholding requirements
applicable to the Option exercise. Optionee acknowledges and agrees that the Company may refuse to honor the exercise and refuse to deliver
the Shares if withholding amounts are not delivered at the time of exercise.

 

(b) Notice of Disqualifying
Disposition of ISO Shares. If the Option granted to Optionee is an Incentive Stock Option (“ISO”), and if
Optionee sells or otherwise disposes of any of the Shares acquired pursuant to the ISO on or before the later of (i) the date two
(2) years after the Grant Date, or (ii) the date one (1) year after the date of exercise, the Optionee must immediately notify the
Company of the disposition in writing. Optionee agrees that Optionee may be subject to income tax withholding by the Company on the compensation
income recognized by the Optionee.

 

(c) Code Section 409A.
Under Code section 409A, an Option that was granted with a per Share exercise price that is determined by the Internal Revenue Service
(the “IRS”) to be less than the Fair Market Value of a Share on the Grant Date (a “discount option”)
may be considered deferred compensation. An Option that is a discount option may result in (i) income recognition by the Optionee prior
to the exercise of the Option, (ii) an additional twenty percent (20%) tax, and (iii) potential penalty and interest charges. Optionee
acknowledges that the Company cannot and has not guaranteed that the IRS will agree that the per Share Exercise Price of this Option equals
or exceeds Fair Market Value of a Share on the Grant Date in a later examination. Optionee agrees that if the IRS determines that the
Option was granted with a per Share exercise price that was less than the Fair Market Value of a Share on the Grant Date, Optionee will
be solely responsible for any and all resulting tax consequences.

 

8. No Guarantee of Continued
Service. OPTIONEE ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING
AS AN EMPLOYEE AND/OR DIRECTOR (AS APPLICABLE) AT THE WILL OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING OPTIONEE)
AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER. OPTIONEE FURTHER ACKNOWLEDGES AND AGREES
THAT THIS OPTION AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS
OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS AN EMPLOYEE AND/OR DIRECTOR (AS APPLICABLE) FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT
ALL, AND WILL NOT INTERFERE IN ANY WAY WITH OPTIONEE’S RIGHT OR THE RIGHT OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING
OR RETAINING OPTIONEE) TO TERMINATE OPTIONEE’S RELATIONSHIP AS AN EMPLOYEE OR DIRECTOR AT ANY TIME, WITH OR WITHOUT CAUSE.

 

    2022 Stock Option Agreement
Option Number XX-XXXX-X
Page 4 of 9

     

    

 

9. Notices. All notices
or other communications which are required or permitted hereunder will be in writing and sufficient if (i) personally delivered or sent
by telecopy, (ii) sent by nationally-recognized overnight courier or (iii) sent by registered or certified mail, postage prepaid, return
receipt requested, addressed as follows:

 

(a) if to the Optionee, to the
address (or telecopy number) set forth on the Notice of Stock Option Grant; and

 

(b) if to the Company, to its
principal executive office as specified in any report filed by the Company with the Securities and Exchange Commission or to such address
as the Company may have specified to the Optionee in writing, Attention: Corporate Secretary;

 

or to any other address as the
party to whom notice is to be given may have furnished to the other party in writing in accordance herewith. Any communication will be
deemed to have been given (i) when delivered, if personally delivered, or when telecopied, if telecopied, (ii) on the first Business Day
(as hereinafter defined) after dispatch, if sent by nationally-recognized overnight courier and (iii) on the fourth Business Day following
the date on which the piece of mail containing the communication is posted, if sent by mail. As used herein, “Business Day”
means a day that is not a Saturday, Sunday or a day on which banking institutions in the city to which the notice or communication is
to be sent are not required to be open.

 

10. Specific Performance.
Optionee expressly agrees that the Company will be irreparably damaged if the provisions of this Option Agreement and the Plan are not
specifically enforced. Upon a breach or threatened breach of the terms, covenants and/or conditions of this Option Agreement or the Plan
by the Optionee, the Company will, in addition to all other remedies, be entitled to a temporary or permanent injunction, without showing
any actual damage, and/or decree for specific performance, in accordance with the provisions hereof and thereof. The Administrator has
the power to determine what constitutes a breach or threatened breach of this Option Agreement or the Plan. The Administrator’s
determinations will be final and conclusive and binding upon the Optionee.

 

11. No Waiver. No waiver
of any breach or condition of this Option Agreement will be deemed to be a waiver of any other or subsequent breach or condition, whether
of like or different nature.

 

12. Optionee Undertaking.
The Optionee agrees to take whatever additional actions and execute whatever additional documents the Company may in its reasonable judgment
deem necessary or advisable in order to carry out or effect one or more of the obligations or restrictions imposed on the Optionee pursuant
to the express provisions of this Option Agreement.

 

13. Modification of Rights.
The rights of the Optionee are subject to modification and termination in certain events as provided in this Option Agreement and the
Plan.

 

14. Governing Law.
This Agreement is governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to its conflict
or choice of law principles that might otherwise refer construction or interpretation of this Agreement to the substantive law of another
jurisdiction.

 

15. Counterparts; Facsimile
Execution. This Option Agreement may be executed in one or more counterparts, each of which will be deemed to be an original, but
all of which together constitute one and the same instrument. Facsimile execution and delivery of this Option Agreement is legal, valid
and binding execution and delivery for all purposes.

 

16. Entire Agreement.
The Plan, this Option Agreement, and upon execution, the Exercise Notice, constitute the entire agreement of the parties with respect
to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Optionee with respect
to the subject matter hereof, and may not be modified adversely to the Optionee’s interest except by means of a writing signed by
the Company and Optionee.

 

17. Severability. In
the event one or more of the provisions of this Option Agreement should, for any reason, be held to be invalid, illegal or unenforceable
in any respect, such invalidity, illegality or unenforceability will not affect any other provisions of this Option Agreement, and this
Option Agreement will be construed as if such invalid, illegal or unenforceable provision had never been contained herein.

 

18. WAIVER OF JURY TRIAL.
THE OPTIONEE EXPRESSLY, IRREVOCABLY AND UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS OPTION
AGREEMENT AND FOR ANY COUNTERCLAIM THEREIN.

 

[Remainder of page left intentionally blank.]

 

    2022 Stock Option Agreement
Option Number XX-XXXX-X
Page 5 of 9

     

    

 

Optionee acknowledges receipt
of a copy of the Plan and represents that he or she is familiar with the terms and provisions thereof, and accepts this Option subject
to all of the terms and provisions thereof. Optionee has reviewed the Plan and this Option in their entirety, has had an opportunity to
obtain the advice of counsel prior to executing this Option and fully understands all provisions of the Option. Optionee agrees to accept
as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan or this
Option. Optionee further agrees to notify the Company upon any change in the residence address indicated below.

 

	OPTIONEE	 	180 LIFE SCIENCES CORP.	 
	 	      	 	 	 	 
	Signature		 	By:	 	 
	 	 	 	 	 	 
	Print Name:	<<Optionee>>	 	Print Name:	 	 
	 	 	 	 	 	 
	Address:	 	 	Address:	 	 
	 		 	 		 
	 	 	 	 	 	 
	 Date Signed:	 	 	Date Signed:		 

 

    2022 Stock Option Agreement
Option Number XX-XXXX-X
Page 6 of 9

     

    

 

EXHIBIT A

 

2022 OMNIBUS INCENTIVE PLAN

 

EXERCISE NOTICE

 

180 Life Sciences Corp.

3000 El Camino Real, Bldg. 4, Suite 200

Palo Alto, California 94306

 

Attention: 180 Life Sciences Corp., Corporate
Secretary

 

1.  Exercise
of Option. Effective as of today, _____________, _____,

___________ (“Optionee”) elects to exercise Optionee’s option to purchase ___________ shares of the Company
Common Stock (the “Shares”) of 180 Life Sciences Corp. (the “Company”) under and pursuant
to the 180 Life Sciences Corp. 2022 Omnibus Incentive Plan (as amended from time to time, the “Plan”) and the
Stock Option Agreement effective <<Grant Date>> (the “Option Agreement”).

 

2.  Delivery
of Payment. Optionee herewith delivers to the Company the full purchase price of the Shares, as set forth in the Option Agreement,
and any and all withholding taxes due in connection with the exercise of the Option.

 

3.  Representations
of Optionee. Optionee acknowledges that Optionee has received, read and understood the Plan and the Option Agreement and agrees to
abide by and be bound by their terms and conditions.

 

4.  Rights
as Stockholder. Until the issuance of the Shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized
transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder exists with respect to the
Optioned Stock, notwithstanding the exercise of the Option. Subject to the requirements of Section 6 below, the Shares
will be issued to the Optionee as soon as practicable after the Option is exercised in accordance with the Option Agreement. No adjustment
will be made for a dividend or other right for which the record date is prior to the date of issuance except as provided in the Plan.

 

5.  Tax
Consultation. Optionee understands that Optionee may suffer adverse tax consequences as a result of Optionee’s purchase or disposition
of the Shares. Optionee represents that Optionee has consulted with any tax consultants Optionee deems advisable in connection with the
purchase or disposition of the Shares and that Optionee is not relying on the Company for any tax advice.

 

6.  Refusal
to Transfer. The Company will not (i) transfer on its books any Shares that have been sold or otherwise transferred in violation of
any of the provisions of this Exercise Notice, or (ii) be required to treat as owner of such Shares or to accord the right to vote or
pay dividends to any purchaser or other transferee to whom such Shares have been so transferred.

 

    2022 Stock Option Agreement
Option Number XX-XXXX-X
Page 7 of 9

     

    

 

7.  Successors
and Assigns. The Company may assign any of its rights under this Exercise Notice to single or multiple assignees, and this Exercise
Notice inures to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this
Exercise Notice is binding upon Optionee and his or her heirs, executors, administrators, successors and assigns.

 

8.  Interpretation.
Any dispute regarding the interpretation of this Exercise Notice will be submitted by Optionee or by the Company forthwith to the Administrator
for review at its next regular meeting. The resolution of disputes by the Administrator will be final and binding on all parties.

 

9.  Governing
Law; Severability. This Exercise Notice is governed by, and construed in accordance with, the laws of the State of Delaware, without
giving effect to its conflict or choice of law principles that might otherwise refer construction or interpretation of this Exercise to
the substantive law of another jurisdiction. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction
to be illegal, unenforceable or void, this Exercise Notice will continue in full force and effect.

 

		10.	Optionee Representations.

 

(a) With
respect to a transaction occurring prior to such date as the Plan and Company Common Stock thereunder are covered by a valid Form S-8
or similar U.S. federal registration statement, Optionee agrees that in no event shall Optionee make a disposition of any of the Company
Common Stock, unless and until: (i) Optionee shall have notified the Company of the proposed disposition and shall have furnished the
Company with a statement of the circumstances surrounding the proposed disposition; and (ii) Optionee shall have furnished the Company
with an opinion of counsel satisfactory to the Company to the effect that (A) such disposition will not require registration or qualification
of such Company Common Stock under applicable U.S. federal, state or foreign securities laws or (B) appropriate action necessary for compliance
with the U.S. federal, state or foreign securities laws has been taken; or (iii) the Company shall have waived, expressly and in writing,
its rights under clauses (i) and (ii) of this Subsection.

 

(b) Optionee
understands that if a registration statement covering the Company Common Stock under the Securities Act is not in effect when Optionee
desires to sell the Company Common Stock, Optionee may be required to hold the Company Common Stock for an indeterminate period. Optionee
also acknowledges that Optionee understands that any sale of the Company Common Stock which might be made by Optionee in reliance upon
Rule 144 under the Securities Act may be made only in limited amounts in accordance with the terms and conditions of that Rule.

 

11. Other
Documents. Optionee hereby acknowledges receipt or the right to receive a document providing the information required by Rule 428(b)(1)
promulgated under the Securities Act of 1933, as amended, including, but not limited to, the information required by Part I of Form S-8,
if applicable.

 

12.  Notices.
Any notice required or permitted hereunder will be provided in writing and deemed effective if provided in the manner specified in the
Option Agreement.

 

13.  Further
Instruments. The parties agree to execute any further instruments and to take any further action as may be reasonably necessary to
carry out the purposes and intent of the Option Agreement and this Exercise Notice.

 

14.  Entire
Agreement. The Plan and Option Agreement are incorporated herein by reference. This Exercise Notice, the Plan, and the Option Agreement
constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings
and agreements of the Company and Optionee with respect to the subject matter hereof, and may not be modified adversely to the Optionee’s
interest except by means of a writing signed by the Company and Optionee.

 

[Signature page follows.]

 

    2022 Stock Option Agreement
Option Number XX-XXXX-X
Page 8 of 9

     

    

 

	Submitted by:	 	Accepted by:	 
	 	 	 	 
	OPTIONEE	 	180 LIFE SCIENCES CORP.	 
	 	 	 	 	 	 
	Signature	 	 	By:	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	Print Name: 	<<Optionee>>	 	Print Name:	 	 
	 	 	 	 	 	 
	Address:	 	 	 	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	 	 	 	Date Received: 	 	 

 

 

 

2022 Stock Option Agreement

Option Number XX-XXXX-X

Page 9   of 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]